Preventing opioid misuse in chronic pain treatment in Norway
Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain
This study is testing new group treatment methods to help people with chronic pain in Norway manage their pain without relying on opioids.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years to 67 Years |
| Sex | All |
| Sponsor | Helse Stavanger HF Government |
| Locations | 1 site (Stavanger) |
| Trial ID | NCT05828121 on ClinicalTrials.gov |
What this trial studies
This project aims to address the rising opioid epidemic in Norway by optimizing treatment for patients with chronic, non-cancer pain. It focuses on developing and testing non-drug interventions through interdisciplinary group treatment to minimize opioid use and improve patients' quality of life. The study will involve collaboration between healthcare providers and patients to enhance treatment strategies and reduce the risks associated with opioid prescriptions. The ultimate goal is to prevent the escalation of opioid use and its negative societal impacts.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 67 with non-malignant chronic pain lasting less than 10 years, residing in Stavanger municipality.
Not a fit: Patients with malignant pain conditions will not benefit from this study.
Why it matters
Potential benefit: If successful, this project could significantly reduce opioid dependency and improve the quality of life for patients suffering from chronic pain.
How similar studies have performed: Other studies have shown success in implementing non-drug interventions for chronic pain management, indicating potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * non-malignant, chronic pain * Registered in Stavanger municipality * Consent to participation. * Age 18 - 67 years * Pain duration \<10 years Exclusion Criteria: * malignant pain condition
Where this trial is running
Stavanger
- Stavanger municipality — Stavanger, Norway (Recruiting)
Study contacts
- Study coordinator: Kine Gjesdal, PhD
- Email: kine.gjesdal@sus.no
- Phone: 004748136702
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.